Price Transparency

Price transparency is moving from a compliance exercise toward a core infrastructure layer for VBC contracting, benefit design, payment integrity, and employer purchasing, as CMS under the Trump administration continues tightening hospital price transparency expectations and stakeholders push for more usable negotiated-rate data rather than static machine-readable files. The next policy frontier is broader cross-market transparency—hospital, payer, PBM, and prescription-drug pricing—creating strategic pressure on ACOs, health systems, and payers to connect price data with clinical quality, referral management, and total-cost-of-care performance rather than treating transparency as a consumer shopping tool alone. The key tension is operational: employers and purchasers see growing promise as the policy matures, while providers, PBMs, and plans face rising scrutiny over data completeness, standardization, and how transparency will be used in contracting, steerage, and payment validation (Health Affairs overview; [CMS FAQ update coverage](